Home/Geneius Biotechnology/Alfred Slanetz, PhD, ME
AS

Alfred Slanetz, PhD, ME

President, CEO, Founder

Geneius Biotechnology

Therapeutic Areas

Geneius Biotechnology Pipeline

DrugIndicationPhase
Targeted DiversiTy T-cellsEBV+ Lymphomas (e.g., NHL)Pre-clinical